Google, Meta, and Isomorphic Labs Invest $300 Million in Biohub's AI-Driven Biomedical Research
Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs are jointly investing $300 million into the nonprofit biomedical research organization Biohub. Founded by Mark Zuckerberg and Priscilla Chan in 2016, Biohub aims to create a 'virtual cell' using artificial intelligence datasets that will allow researchers to simulate biological processes digitally. This investment is part of an overall $1.8 billion initiative aimed at accelerating scientific discovery through AI-driven modeling. The U.S. Department of Energy has also pledged over $500 million in funding, while the National Institutes of Health will contribute valuable data resources from prior federal investments exceeding $500 million. Alex Rives, Biohub’s head of science, emphasized that an accurate predictive model could transform how scientists conduct experiments and accelerate disease prevention efforts. The collaboration highlights a growing trend among tech giants to leverage AI in biomedical research, potentially reshaping drug discovery and healthcare innovation.
